Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 42,664 shares at $79.17 ($3.4M) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $3.4M IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.17 | 13,526 | $1.1M | 31.6% |
| 2 | $79.17 | 13,526 | $1.1M | 31.6% |
| 3 | $80.00 | 6,794 | $543K | 16.0% |
| 4 | $80.00 | 6,794 | $544K | 16.0% |
| 5 | $80.82 | 1,012 | $82K | 2.4% |
| 6 | $80.82 | 1,012 |
| $82K |
| 2.4% |
| Total | $79.51 avg | 42,664 | $3.4M | 100% |
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |
| IONS | SELL | 2025-09-04 | $1.7M | — | Filing → |